Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)

被引:5
|
作者
Puleo, Christopher W. [1 ]
Ayers, Colby R. [2 ]
Garg, Sonia [2 ]
Neeland, Ian J. [2 ]
Lewis, Alana A. [2 ]
Pandey, Ambarish [2 ]
Drazner, Mark H. [2 ]
de Lemos, James A. [2 ]
机构
[1] Ochsner Med Ctr, Heart & Vasc Inst, 1514 Jefferson Highway, New Orleans, LA 70121 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
biostatistics; cardiology; heart failure; NATRIURETIC PEPTIDE LEVELS; LEFT-VENTRICULAR HYPERTROPHY; C-REACTIVE PROTEIN; ATHEROSCLEROSIS RISK; GENERAL-POPULATION; PROGNOSTIC VALUE; IMPACT; ASSAY; MORTALITY; FAILURE;
D O I
10.2217/bmm-2021-0055
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) associate with structural heart disease and heart failure risk in individuals without known cardiovascular disease (CVD). However, few data are available regarding whether factors influencing levels of these two biomarkers are similar or distinct. We performed serial measurement of NT-proBNP and hs-cTnT in a contemporary multiethnic cohort with extensive phenotyping, with the goal of identifying their respective biological determinants in a population without known or suspected CVD. Methods: We evaluated 1877 participants of the Dallas Heart Study who had NT-proBNP and hs-cTnT measured and were free from clinical CVD at the each of its two examinations (2000-2002 and 2007-2009). Variables collected included demographic and risk factors, high-sensitivity C-reactive protein, body composition via dual-energy x-ray absorptiometry, coronary artery calcium by computed tomography, and cardiac dimensions and function by cardiac MRI. Linear regression was used to identify associations of these factors with each biomarker at baseline and with changes in biomarkers over follow-up. Results: NT-proBNP and hs-cTnT were poorly correlated at baseline (Spearman rho 0.083, p = 0.015), with only moderate correlation between change values (rho 0.18, p < 0.001). hs-cTnT positively associated and NT-proBNP inversely associated with male gender and black race. At baseline, both NT-proBNP and hs-cTnT associated with left ventricular end-diastolic volume and wall thickness, but only NT-proBNP associated with left atrial size. Changes in cardiac dimensions between phases were more strongly associated with changes in NT-proBNP than hs-cTnT. NT-proBNP was more strongly associated with high-sensitivity C-reactive protein and measures of body composition than hs-cTnT. Conclusion: Among individuals without CVD in the general population, NT-proBNP and hs-cTnT are nonredundant biomarkers that are differentially associated with demographic and cardiac factors. These findings indicate that hs-cTnT and NT-proBNP may reflect different pathophysiological pathways.
引用
收藏
页码:1487 / 1498
页数:12
相关论文
共 50 条
  • [1] Demographic and Biological Factors Associated With Baseline and Serial Changes in Circulating NT-proBNP and High-Sensitivity Cardiac Troponin T in the Dallas Heart Study.
    Puleo, Christopher W.
    Ayers, Colby R.
    Garg, Sonia
    Drazner, Mark H.
    de Lemos, James
    CIRCULATION, 2018, 138
  • [2] NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis
    Castiglione, Vincenzo
    Aimo, Alberto
    Prontera, Concetta
    Masotti, Silvia
    Musetti, Veronica
    Chubuchny, Vlad
    Spini, Valentina
    Genovesi, Dario
    Barison, Andrea
    Giannoni, Alberto
    Passino, Claudio
    Emdin, Michele
    Vergaro, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J178 - J178
  • [3] NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis
    Castiglione, V.
    Aimo, A.
    Barison, A.
    Genovesi, D.
    Prontera, C.
    Masotti, S.
    Giannoni, A.
    Spini, V.
    Taddei, C.
    Passino, C.
    Emdin, M.
    Vergaro, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1680 - 1680
  • [4] High-sensitivity cardiac troponin I and NT-proBNP and their relationship to heart failure in the European BiomarCaRE population
    Yan, I.
    Boerschel, C.
    Neumann, J.
    Spruenker, N.
    Kontto, J.
    Kuulasmaa, K.
    Salomaa, V.
    Iacoviello, L.
    Di Castelnuovo, A.
    Costanzo, S.
    Linneberg, A.
    Soederberg, S.
    Zeller, T.
    Blankenberg, S.
    Westermann, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 944 - 944
  • [5] NT-PROBNP AND HIGH-SENSITIVITY TROPONIN T HOLD DIAGNOSTIC VALUE IN CARDIAC AMYLOIDOSIS
    Castiglione, Vincenzo
    Aimo, Alberto
    Prontera, Concetta
    Masotti, Silvia
    Musetti, Veronica
    Nicol, Martin
    Cohen-solal, Alain
    Logeart, Damien
    Georgiopoulos, Georgios
    Chubuchny, Vladyslav
    Giannoni, Alberto
    Clerico, Aldo
    Buda, Gabriele
    Patel, Kiara N.
    Razvi, Yousuf
    Patel, Rishi
    Wechalekar, Ashutosh
    Lachman, Helen
    Hawkins, Philip N.
    Passino, Claudio
    Gillmore, Julian
    Emdin, Michele
    Fontana, Marianna
    Vergaro, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [6] High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINT
    Haney, Devin
    Ma, Yuan
    Dalmacy, Djhenne
    Pajewski, Nicholas M.
    Hajjar, Ihab
    de Lemos, James A.
    Zhang, Wenxin
    Soliman, Elsayed Z.
    Ballantyne, Christie M.
    Nambi, Vijay
    Sattar, Naveed
    Killeen, Anthony A.
    Ix, Joachim H.
    Shlipak, Michael G.
    Berry, Jarett D.
    Ascher, Simon B.
    HYPERTENSION, 2024, 81 (09) : 1956 - 1965
  • [7] NT-ProBNP and high-sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population
    Averina, Maria
    Stylidis, Michael
    Brox, Jan
    Schirmer, Henrik
    ESC HEART FAILURE, 2022, 9 (03): : 1954 - 1962
  • [8] Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP
    Kopec, Michael
    Duma, Andreas
    Helwani, Mohammad A.
    Brown, Jamie
    Brown, Frank
    Gage, Brian F.
    Gibson, David W.
    Miller, J. Philip
    Novak, Eric
    Jaffe, Allan S.
    Apple, Fred S.
    Scott, Mitchell G.
    Nagele, Peter
    ANESTHESIA AND ANALGESIA, 2017, 124 (02): : 398 - 405
  • [9] High-Sensitivity Cardiac Troponin T and NT-proBNP in Cardiovascular Risk Prediction in Persons with Diabetes
    Parrinello, Christina M.
    Mcevoy, John W.
    Woodward, Mark
    Folsom, Aaron R.
    Ballantyne, Christie M.
    Coresh, Josef
    Selvin, Elizabeth
    DIABETES, 2014, 63 : A351 - A351
  • [10] Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure
    Aimo, A.
    Januzzi, J. L.
    Mueller, C.
    Miro, O.
    Pascual Figal, D.
    Jacob, J.
    Herrero-Puente, P.
    Llorens, P.
    Wussler, D.
    Kozhuharov, N.
    Sabti, Z.
    Breidthardt, T.
    Vergaro, G.
    Prontera, C.
    Emdin, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 17 - 17